Loading company…
Wyze develops DNT immune cell therapies and related biomedical products.
Founded in 2012 and based in Zhongshan, China, Wyze develops DNT immune cell drugs for patients with malignant tumors and autoimmune diseases. Its business also includes stem cell and immunobiology research, diagnostic reagents, and products such as NALE antibodies and CAR-T cells. In 2021, it changed its name from Zhejiang Ruishun Biotechnology Co., Ltd. to Guangdong Ruishun Biotechnology Co., Ltd.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in